nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproterone acetate—Rash—Topotecan—peripheral nervous system neoplasm	0.00061	0.000611	CcSEcCtD
Cyproterone acetate—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00061	0.00061	CcSEcCtD
Cyproterone acetate—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00061	0.00061	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000608	0.000608	CcSEcCtD
Cyproterone acetate—Cough—Etoposide—peripheral nervous system neoplasm	0.000607	0.000608	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000607	0.000607	CcSEcCtD
Cyproterone acetate—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.000607	0.000607	CcSEcCtD
Cyproterone acetate—Headache—Topotecan—peripheral nervous system neoplasm	0.000607	0.000607	CcSEcCtD
Cyproterone acetate—Rash—Tretinoin—peripheral nervous system neoplasm	0.000606	0.000606	CcSEcCtD
Cyproterone acetate—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000606	0.000606	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000606	0.000606	CcSEcCtD
Cyproterone acetate—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000605	0.000606	CcSEcCtD
Cyproterone acetate—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000605	0.000605	CcSEcCtD
Cyproterone acetate—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000605	0.000605	CcSEcCtD
Cyproterone acetate—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000605	0.000605	CcSEcCtD
Cyproterone acetate—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000603	0.000603	CcSEcCtD
Cyproterone acetate—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000602	0.000603	CcSEcCtD
Cyproterone acetate—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000602	0.000602	CcSEcCtD
Cyproterone acetate—Headache—Tretinoin—peripheral nervous system neoplasm	0.000602	0.000602	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.0006	0.0006	CcSEcCtD
Cyproterone acetate—Constipation—Vincristine—peripheral nervous system neoplasm	0.0006	0.0006	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.0006	0.0006	CcSEcCtD
Cyproterone acetate—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000598	0.000599	CcSEcCtD
Cyproterone acetate—Rash—Melphalan—peripheral nervous system neoplasm	0.000598	0.000598	CcSEcCtD
Cyproterone acetate—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000597	0.000597	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000595	0.000595	CcSEcCtD
Cyproterone acetate—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000591	0.000591	CcSEcCtD
Cyproterone acetate—Migraine—Doxorubicin—peripheral nervous system neoplasm	0.00059	0.00059	CcSEcCtD
Cyproterone acetate—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.00059	0.00059	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000589	0.000589	CcSEcCtD
Cyproterone acetate—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000586	0.000586	CcSEcCtD
Cyproterone acetate—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000586	0.000586	CcSEcCtD
Cyproterone acetate—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000584	0.000584	CcSEcCtD
Cyproterone acetate—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00058	0.00058	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000578	0.000579	CcSEcCtD
Cyproterone acetate—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000578	0.000578	CcSEcCtD
Cyproterone acetate—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000575	0.000576	CcSEcCtD
Cyproterone acetate—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000575	0.000576	CcSEcCtD
Cyproterone acetate—Nausea—Topotecan—peripheral nervous system neoplasm	0.000575	0.000575	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000574	0.000574	CcSEcCtD
Cyproterone acetate—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000572	0.000572	CcSEcCtD
Cyproterone acetate—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000572	0.000572	CcSEcCtD
Cyproterone acetate—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00057	0.000571	CcSEcCtD
Cyproterone acetate—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00057	0.000571	CcSEcCtD
Cyproterone acetate—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000568	0.000568	CcSEcCtD
Cyproterone acetate—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000563	0.000563	CcSEcCtD
Cyproterone acetate—Nausea—Melphalan—peripheral nervous system neoplasm	0.000563	0.000563	CcSEcCtD
Cyproterone acetate—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000562	0.000562	CcSEcCtD
Cyproterone acetate—Asthma—Epirubicin—peripheral nervous system neoplasm	0.00056	0.00056	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000556	0.000557	CcSEcCtD
Cyproterone acetate—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000555	0.000555	CcSEcCtD
Cyproterone acetate—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000554	0.000555	CcSEcCtD
Cyproterone acetate—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000554	0.000555	CcSEcCtD
Cyproterone acetate—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000554	0.000554	CcSEcCtD
Cyproterone acetate—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000553	0.000553	CcSEcCtD
Cyproterone acetate—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000552	0.000552	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000549	0.00055	CcSEcCtD
Cyproterone acetate—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000549	0.000549	CcSEcCtD
Cyproterone acetate—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000542	0.000542	CcSEcCtD
Cyproterone acetate—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000542	0.000542	CcSEcCtD
Cyproterone acetate—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.00054	0.00054	CcSEcCtD
Cyproterone acetate—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000539	0.000539	CcSEcCtD
Cyproterone acetate—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000537	0.000537	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000536	0.000537	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000535	0.000536	CcSEcCtD
Cyproterone acetate—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000531	0.000531	CcSEcCtD
Cyproterone acetate—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000529	0.000529	CcSEcCtD
Cyproterone acetate—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000529	0.000529	CcSEcCtD
Cyproterone acetate—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000522	0.000522	CcSEcCtD
Cyproterone acetate—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000518	0.000518	CcSEcCtD
Cyproterone acetate—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000517	0.000518	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000517	0.000517	CcSEcCtD
Cyproterone acetate—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000515	0.000515	CcSEcCtD
Cyproterone acetate—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000511	0.000511	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000511	0.000511	CcSEcCtD
Cyproterone acetate—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.00051	0.00051	CcSEcCtD
Cyproterone acetate—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000508	0.000508	CcSEcCtD
Cyproterone acetate—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000507	0.000507	CcSEcCtD
Cyproterone acetate—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000507	0.000507	CcSEcCtD
Cyproterone acetate—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000505	0.000505	CcSEcCtD
Cyproterone acetate—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000503	0.000503	CcSEcCtD
Cyproterone acetate—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000499	0.000499	CcSEcCtD
Cyproterone acetate—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000498	0.000498	CcSEcCtD
Cyproterone acetate—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000495	0.000495	CcSEcCtD
Cyproterone acetate—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000494	0.000494	CcSEcCtD
Cyproterone acetate—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000491	0.000491	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000491	0.000491	CcSEcCtD
Cyproterone acetate—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00049	0.00049	CcSEcCtD
Cyproterone acetate—Fatigue—Etoposide—peripheral nervous system neoplasm	0.00049	0.00049	CcSEcCtD
Cyproterone acetate—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000487	0.000487	CcSEcCtD
Cyproterone acetate—Constipation—Etoposide—peripheral nervous system neoplasm	0.000486	0.000486	CcSEcCtD
Cyproterone acetate—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000481	0.000482	CcSEcCtD
Cyproterone acetate—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00048	0.00048	CcSEcCtD
Cyproterone acetate—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000479	0.000479	CcSEcCtD
Cyproterone acetate—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000479	0.000479	CcSEcCtD
Cyproterone acetate—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000476	0.000476	CcSEcCtD
Cyproterone acetate—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000473	0.000473	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000472	0.000472	CcSEcCtD
Cyproterone acetate—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000472	0.000472	CcSEcCtD
Cyproterone acetate—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000469	0.000469	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000468	0.000468	CcSEcCtD
Cyproterone acetate—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000467	0.000468	CcSEcCtD
Cyproterone acetate—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000466	0.000467	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000465	0.000465	CcSEcCtD
Cyproterone acetate—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000464	0.000464	CcSEcCtD
Cyproterone acetate—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000463	0.000463	CcSEcCtD
Cyproterone acetate—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000459	0.000459	CcSEcCtD
Cyproterone acetate—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000459	0.000459	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000457	0.000457	CcSEcCtD
Cyproterone acetate—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000456	0.000456	CcSEcCtD
Cyproterone acetate—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000454	0.000454	CcSEcCtD
Cyproterone acetate—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000451	0.000452	CcSEcCtD
Cyproterone acetate—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000451	0.000451	CcSEcCtD
Cyproterone acetate—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.00045	0.000451	CcSEcCtD
Cyproterone acetate—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000449	0.000449	CcSEcCtD
Cyproterone acetate—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000449	0.000449	CcSEcCtD
Cyproterone acetate—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000448	0.000448	CcSEcCtD
Cyproterone acetate—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000448	0.000448	CcSEcCtD
Cyproterone acetate—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000446	0.000446	CcSEcCtD
Cyproterone acetate—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000445	0.000445	CcSEcCtD
Cyproterone acetate—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000443	0.000443	CcSEcCtD
Cyproterone acetate—Rash—Vincristine—peripheral nervous system neoplasm	0.000442	0.000442	CcSEcCtD
Cyproterone acetate—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000442	0.000442	CcSEcCtD
Cyproterone acetate—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000441	0.000441	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000441	0.000441	CcSEcCtD
Cyproterone acetate—Headache—Vincristine—peripheral nervous system neoplasm	0.000439	0.00044	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000437	0.000437	CcSEcCtD
Cyproterone acetate—Megestrol acetate—ABCB1—peripheral nervous system neoplasm	0.000434	1	CrCbGaD
Cyproterone acetate—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000432	0.000433	CcSEcCtD
Cyproterone acetate—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000432	0.000432	CcSEcCtD
Cyproterone acetate—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000424	0.000425	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000424	0.000424	CcSEcCtD
Cyproterone acetate—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000419	0.000419	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000419	0.000419	CcSEcCtD
Cyproterone acetate—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000417	0.000417	CcSEcCtD
Cyproterone acetate—Nausea—Vincristine—peripheral nervous system neoplasm	0.000417	0.000417	CcSEcCtD
Cyproterone acetate—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000415	0.000415	CcSEcCtD
Cyproterone acetate—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000415	0.000415	CcSEcCtD
Cyproterone acetate—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000408	0.000408	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000408	0.000408	CcSEcCtD
Cyproterone acetate—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000407	0.000407	CcSEcCtD
Cyproterone acetate—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000405	0.000405	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000404	0.000404	CcSEcCtD
Cyproterone acetate—Chills—Epirubicin—peripheral nervous system neoplasm	0.000402	0.000402	CcSEcCtD
Cyproterone acetate—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000402	0.000402	CcSEcCtD
Cyproterone acetate—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.0004	0.0004	CcSEcCtD
Cyproterone acetate—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000396	0.000396	CcSEcCtD
Cyproterone acetate—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000394	0.000394	CcSEcCtD
Cyproterone acetate—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000393	0.000393	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000392	0.000392	CcSEcCtD
Cyproterone acetate—Rash—Cisplatin—peripheral nervous system neoplasm	0.000391	0.000391	CcSEcCtD
Cyproterone acetate—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000391	0.000391	CcSEcCtD
Cyproterone acetate—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.00039	0.00039	CcSEcCtD
Cyproterone acetate—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000389	0.000389	CcSEcCtD
Cyproterone acetate—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000388	0.000388	CcSEcCtD
Cyproterone acetate—Tension—Epirubicin—peripheral nervous system neoplasm	0.000383	0.000383	CcSEcCtD
Cyproterone acetate—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000376	0.000376	CcSEcCtD
Cyproterone acetate—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000376	0.000376	CcSEcCtD
Cyproterone acetate—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000375	0.000375	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000374	0.000374	CcSEcCtD
Cyproterone acetate—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000372	0.000372	CcSEcCtD
Cyproterone acetate—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000368	0.000369	CcSEcCtD
Cyproterone acetate—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000367	0.000367	CcSEcCtD
Cyproterone acetate—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000363	0.000364	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000362	0.000362	CcSEcCtD
Cyproterone acetate—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000361	0.000361	CcSEcCtD
Cyproterone acetate—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000361	0.000361	CcSEcCtD
Cyproterone acetate—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000361	0.000361	CcSEcCtD
Cyproterone acetate—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000359	0.000359	CcSEcCtD
Cyproterone acetate—Rash—Etoposide—peripheral nervous system neoplasm	0.000358	0.000358	CcSEcCtD
Cyproterone acetate—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000358	0.000358	CcSEcCtD
Cyproterone acetate—Headache—Etoposide—peripheral nervous system neoplasm	0.000356	0.000356	CcSEcCtD
Cyproterone acetate—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000354	0.000354	CcSEcCtD
Cyproterone acetate—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000352	0.000352	CcSEcCtD
Cyproterone acetate—Syncope—Epirubicin—peripheral nervous system neoplasm	0.00035	0.00035	CcSEcCtD
Cyproterone acetate—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000349	0.000349	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000343	0.000343	CcSEcCtD
Cyproterone acetate—Cough—Epirubicin—peripheral nervous system neoplasm	0.000341	0.000341	CcSEcCtD
Cyproterone acetate—Nausea—Etoposide—peripheral nervous system neoplasm	0.000337	0.000338	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000335	0.000335	CcSEcCtD
Cyproterone acetate—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000334	0.000334	CcSEcCtD
Cyproterone acetate—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000332	0.000332	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.00033	0.00033	CcSEcCtD
Cyproterone acetate—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000328	0.000328	CcSEcCtD
Cyproterone acetate—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000326	0.000326	CcSEcCtD
Cyproterone acetate—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000324	0.000324	CcSEcCtD
Cyproterone acetate—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000323	0.000323	CcSEcCtD
Cyproterone acetate—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000318	0.000319	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000317	0.000317	CcSEcCtD
Cyproterone acetate—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000315	0.000315	CcSEcCtD
Cyproterone acetate—Shock—Epirubicin—peripheral nervous system neoplasm	0.000313	0.000313	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000312	0.000312	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000312	0.000312	CcSEcCtD
Cyproterone acetate—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000311	0.000311	CcSEcCtD
Cyproterone acetate—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000309	0.000309	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000308	0.000308	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000305	0.000305	CcSEcCtD
Cyproterone acetate—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000304	0.000304	CcSEcCtD
Cyproterone acetate—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000304	0.000304	CcSEcCtD
Cyproterone acetate—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000298	0.000298	CcSEcCtD
Cyproterone acetate—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000295	0.000295	CcSEcCtD
Cyproterone acetate—Shock—Doxorubicin—peripheral nervous system neoplasm	0.00029	0.00029	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000289	0.000289	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000289	0.000289	CcSEcCtD
Cyproterone acetate—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000288	0.000288	CcSEcCtD
Cyproterone acetate—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000286	0.000286	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000285	0.000285	CcSEcCtD
Cyproterone acetate—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000284	0.000284	CcSEcCtD
Cyproterone acetate—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000281	CcSEcCtD
Cyproterone acetate—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.00028	0.00028	CcSEcCtD
Cyproterone acetate—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000277	0.000277	CcSEcCtD
Cyproterone acetate—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000275	0.000275	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000275	0.000275	CcSEcCtD
Cyproterone acetate—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000275	0.000275	CcSEcCtD
Cyproterone acetate—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000272	0.000272	CcSEcCtD
Cyproterone acetate—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000263	0.000263	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000262	0.000263	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.00026	0.000261	CcSEcCtD
Cyproterone acetate—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000259	0.00026	CcSEcCtD
Cyproterone acetate—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000256	0.000256	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000254	0.000255	CcSEcCtD
Cyproterone acetate—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000254	0.000254	CcSEcCtD
Cyproterone acetate—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000253	0.000253	CcSEcCtD
Cyproterone acetate—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.000252	CcSEcCtD
Cyproterone acetate—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000252	0.000252	CcSEcCtD
Cyproterone acetate—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000252	0.000252	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.000243	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000241	0.000241	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000235	0.000235	CcSEcCtD
Cyproterone acetate—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.000234	CcSEcCtD
Cyproterone acetate—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000233	0.000233	CcSEcCtD
Cyproterone acetate—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000233	0.000233	CcSEcCtD
Cyproterone acetate—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000229	0.000229	CcSEcCtD
Cyproterone acetate—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000225	0.000225	CcSEcCtD
Cyproterone acetate—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000218	0.000218	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.000217	CcSEcCtD
Cyproterone acetate—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.000212	CcSEcCtD
Cyproterone acetate—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000211	0.000211	CcSEcCtD
Cyproterone acetate—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000209	CcSEcCtD
Cyproterone acetate—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000203	CcSEcCtD
Cyproterone acetate—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.000202	CcSEcCtD
Cyproterone acetate—Rash—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000201	CcSEcCtD
Cyproterone acetate—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000201	CcSEcCtD
Cyproterone acetate—Headache—Epirubicin—peripheral nervous system neoplasm	0.0002	0.0002	CcSEcCtD
Cyproterone acetate—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000195	CcSEcCtD
Cyproterone acetate—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000189	0.000189	CcSEcCtD
Cyproterone acetate—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000187	CcSEcCtD
Cyproterone acetate—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000186	CcSEcCtD
Cyproterone acetate—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000186	CcSEcCtD
Cyproterone acetate—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.000185	CcSEcCtD
Cyproterone acetate—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000175	CcSEcCtD
